PharmiWeb.com - Global Pharma News & Resources
14-Jan-2019

CLARITIN Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com

The "CLARITIN Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.

CLARITIN Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs. The report focuses on CLARITIN and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Topics Covered

  • Profile for CLARITIN
  • US Patents
  • Expired US Patents
  • US District Court Litigation
  • International (ex US) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources

Companies Featured

  • Bayer Healthcare
  • Lil' Drug Store Products
  • Sigma-Aldrich
  • Molport
  • Abi Chem
  • Vitas-M Laboratory
  • Forechem
  • Chemmol
  • Abblis Chemicals
  • Biochempartner
  • Medchemexpress Mce
  • Abachemscene
  • Mcule
  • Synblock Inc
  • Act Chemical
  • An Pharmatech
  • Syntree
  • Founder Pharma
  • Labseeker
  • Avachem Scientific
  • Bide Pharmatech Ltd.
  • Tocris Bioscience
  • Biosynth
  • Oxchem Corporation
  • Clearsynth
  • Phion Ltd
  • Enovation Chemicals
  • Abovchem Llc
  • LGC Standards
  • Activate Scientific
  • Ochem
  • King Scientific
  • 001Chemical
  • Ambeed
  • and many more...

For more information about this report visit https://www.researchandmarkets.com/research/wn2vml/claritin_drug?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005404/en/

Editor Details

Last Updated: 14-Jan-2019